Argonaut Manufacturing Services, a CDMO specializing in aseptic fill-finish for injectable biologics and other drugs, has sold its life sciences and diagnostics unit to the private...
Merck pursues new cancer combinations, prediction markets put pharma’s confidential information in focus and personalized cancer vaccines confront manufacturing hurdles.
A new study showed that a prgrammed lysis approach cut mechanical separation energy by over 50 percent at pilot scale, widening the range of bioalternatives that...
Advances in media optimization, cell engineering, and AI are reshaping intensified bioprocessing for higher productivity, better quality, and greater manufacturing efficiency. The post Smarter Cell Culture...
A majority of biopharmas are expected to increase their reliance on CDMOs in coming years despite rising costs for their services. The post Top 10 Contract...
As one notable company exits the field, growing CDMOs open facilities and secure major contracts. The companies are listed here for making headlines with facility openings,...
Lonza's plans for a new spray-drying facility in Bend, Oregon, affirm the company's commitment both to high-margin medicines and the U.S. At the same time, fellow...
Scan to Read